Expanded Access to Venetoclax

Clinical trial NCT03123029 · AVAILABLE

Trial details

NCT number: NCT03123029
Sponsor: AbbVie
Status: AVAILABLE
Study type: EXPANDED_ACCESS

Chronic Lymphocytic Leukemia (CLL)Multiple Myeloma Acute Myeloid Leukemia (AML)Non-Hodgkin's Lymphoma Acute Lymphoblastic Leukemia (ALL)Amyloidosis Plasma Cell Leukemia

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.